Ledger.Open graph →
SEC Form D · Amendment · filed August 17, 2018

RXi Pharmaceuticals Corp

Offering
$15.3M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MARLBOROUGH, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Paul Dorman · Marlborough, MADirectorRobert Bitterman · Marlborough, MADirectorGerrit Dispersyn · Marlborough, MAExecKeith Brownlie · Marlborough, MADirectorCurtis Lockshin · Marlborough, MADirectorJonathan Freeman · Marlborough, MADirectorRobert Bitterman · Marlborough, MADirectorPaul Dorman · Marlborough, MADirectorJonathan Freeman · Marlborough, MADirectorGerrit Dispersyn · Marlborough, MAExecCurtis Lockshin · Marlborough, MADirectorKeith Brownlie · Marlborough, MADirectorGeert Cauwenbergh · VILLANOVA, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗